Cargando…
Genomics Integration Into Nephrology Practice
RATIONALE & OBJECTIVE: The etiology of kidney disease remains unknown in many individuals with chronic kidney disease (CKD). We created the Mayo Clinic Nephrology Genomics Clinic to improve our ability to integrate genomic and clinical data to identify the etiology of unexplained CKD. STUDY DESI...
Autores principales: | Pinto e Vairo, Filippo, Prochnow, Carri, Kemppainen, Jennifer L., Lisi, Emily C., Steyermark, Joan M., Kruisselbrink, Teresa M., Pichurin, Pavel N., Dhamija, Rhadika, Hager, Megan M., Albadri, Sam, Cornell, Lynn D., Lazaridis, Konstantinos N., Klee, Eric W., Senum, Sarah R., El Ters, Mireille, Amer, Hatem, Baudhuin, Linnea M., Moyer, Ann M., Keddis, Mira T., Zand, Ladan, Sas, David J., Erickson, Stephen B., Fervenza, Fernando C., Lieske, John C., Harris, Peter C., Hogan, Marie C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8551494/ https://www.ncbi.nlm.nih.gov/pubmed/34746741 http://dx.doi.org/10.1016/j.xkme.2021.04.014 |
Ejemplares similares
-
Nail-patella-like renal disease masquerading as Fabry disease on kidney biopsy: a case report
por: Pinto e Vairo, Filippo, et al.
Publicado: (2020) -
Pathogenic Variant in ACTB, p.Arg183Trp, Causes Juvenile-Onset Dystonia, Hearing Loss, and Developmental Delay without Midline Malformation
por: Conboy, Erin, et al.
Publicado: (2017) -
Safety and Efficacy of Daratumumab in Patients with Proliferative GN with Monoclonal Immunoglobulin Deposits
por: Zand, Ladan, et al.
Publicado: (2021) -
Anti-CD20 should be the first-line treatment in high-risk membranous nephropathy
por: Zand, Ladan, et al.
Publicado: (2023) -
Microscopic hematuria as a risk factor for IgAN progression: considering this biomarker in selecting and monitoring patients
por: Zand, Ladan, et al.
Publicado: (2023)